Downregulation of HNF-1B in renal cell carcinoma is associated with tumor progression and poor prognosis.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Urology

• Publication date

  2010-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.urology.2010.03.042PMID 20538322
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TNM Classification of Malignant Tumours, 7th Edition

  2009cited by this paper
• A five-gene signature and clinical outcome in non-small-cell lung cancer.

  2007cited by this paper
• Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes

  2007cited by this paper
• Expression profiling of archival renal tumors by quantitative PCR to validate prognostic markers.

  2007cited by this paper
• Hepatocyte nuclear factor-1beta gene deletions--a common cause of renal disease.

  2007cited by this paper
• Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.

  2006cited by this paper
• Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma.

  2006cited by this paper
• Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer.

  2006cited by this paper
• Prognostic factors in renal cell carcinoma.

  2006cited by this paper
• Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines

  2006cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Clear Cell Renal Cell Carcinoma: Gene Expression Analyses Identify a Potential Signature for Tumor Aggressiveness

  2005cited by this paper
• Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.

  2005cited by this paper
• Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas.

  2005cited by this paper
• Gene Signatures of Progression and Metastasis in Renal Cell Cancer

  2005cited by this paper
• Germline hepatocyte nuclear factor 1α and 1β mutations in renal cell carcinomas

  2005cited by this paper
• Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas.

  2005cited by this paper
• Gene expression in kidney cancer is associated with cytogenetic abnormalities, metastasis formation, and patient survival.

  2005cited by this paper
• Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors

  2004cited by this paper
• Semi-Supervised Methods to Predict Patient Survival from Gene Expression Data

  2004cited by this paper
• Robust Classification of Renal Cell Carcinoma Based on Gene Expression Data and Predicted Cytogenetic Profiles

  2004cited by this paper
• Molecular subclassification of kidney tumors and the discovery of new diagnostic markers

  2003cited by this paper
• Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease.

  2003cited by this paper
• Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor

  2003cited by this paper
• Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma.

  2003cited by this paper
• Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1beta.

  2002cited by this paper
• Microdissection is essential for gene expression profiling of clinically resected cancer tissues.

  2002cited by this paper
• Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection.

  2001cited by this paper
• Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification

  2001cited by this paper
• Expression of the vHNF1/HNF1β homeoprotein gene during mouse organogenesis

  1999cited by this paper
• Identification of expressed genes by laser-mediated manipulation of single cells

  1998cited by this paper
• Comparison of the descriptive epidemiology of urinary tract cancers

  1990cited by this paper

• The Landscape of HNF1B Deficiency: A Syndrome Not Yet Fully Explored

  2023cites this paper
• Comprehensive quantitative analysis of alternative splicing variants reveals the HNF1B mRNA splicing pattern in various tumour and non-tumour tissues

  2022cites this paper
• Diagnostic importance of hepatocyte nuclear factor 1 beta (HNF1β) in testicular tumors and its sensitivity for the detection of yolk sac tumors: an immunohistochemical analysis

  2022cites this paper
• Hepatocyte nuclear factor 1 beta: A perspective in cancer

  2021cites this paper
• Perturbation of BRMS1 interactome reveals pathways that impact metastasis

  2021influential citation
• SYDE1 Acts as an Oncogene in Glioma and has Diagnostic and Prognostic Values

  2021cites this paper
• Insights into the etiology and physiopathology of MODY5/HNF1B pancreatic phenotype with a mouse model of the human disease

  2021cites this paper
• Perturbation of BRMS1 interactome reveals pathways that impact cell migration

  2021cites this paper
• Identification of novel HNF1B mRNA splicing variants and their qualitative and semi-quantitative profile in selected healthy and tumour tissues

  2020cites this paper
• Analysis of expression, epigenetic, and genetic changes of HNF1B in 130 kidney tumours

  2020cites this paper
• Investigation of HNF-1 B as a diagnostic biomarker for pancreatic ductal adenocarcinoma

  2019cites this paper
• Hepatocyte nuclear factor-1 beta protects endometriotic cells against apoptotic cell death by up-regulating the expression of antiapoptotic genes†

  2019cites this paper
• Pancreatic Ductal Deletion of Hnf1b Disrupts Exocrine Homeostasis, Leads to Pancreatitis, and Facilitates Tumorigenesis

  2019cites this paper
• DNMT1 recruited by EZH2-mediated silencing of miR-484 contributes to the malignancy of cervical cancer cells through MMP14 and HNF1A

  2019cites this paper
• Investigation of HNF-1B as a diagnostic biomarker for pancreatic ductal adenocarcinoma

  2018cites this paper
• Epigenetically Silenced Candidate Tumor Suppressor Genes in Prostate Cancer: Identified by Modeling Methylation Stratification and Applied to Progression Prediction

  2018cites this paper
• The Role of HNF1B in Tumorigenesis of Solid Tumours: a Review of Current Knowledge.

  2018cites this paper
• Polycystic kidney features of the renal pathology in glycogen storage disease type I: possible evolution to renal neoplasia

  2018cites this paper
• Implication du facteur développemental Lim1, un nouvel oncogène, dans le cancer du rein humain avancé

  2017cites this paper
• HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas.

  2017cites this paper
• Combined expressions of ALEX1 and HNF-1β could improve the ability of differentia tion between squamous cell carcinoma and adenocarcinoma of the uterine-cervix

  2017cites this paper
• Molecular mechanisms underlying the action of histone deacetylases inhibitors (HDACIs) in ovarian cancer

  2017cites this paper
• HNF 1 B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer

  2016cites this paper
• HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer

  2016cites this paper
• Expression, Epigenetic and Genetic Changes of HNF1B in Endometrial Lesions

  2016cites this paper
• A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: Results from the IMMEnSE consortium and meta-analysis

  2016cites this paper
• Are primary renal cell carcinoma and metastases of renal cell carcinoma the same cancer?

  2016cites this paper
• Discoidin Domain Receptors in Health and Disease

  2016cites this paper
• DDRs in Healthy and Cancerous Reproductive Systems

  2016cites this paper
• Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120)

  2015cites this paper
• Fine-mapping of the HNF1Bmulticancer locus identifies candidate variants thatmediate endometrial cancer risk

  2015cites this paper
• Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases

  2015cites this paper
• Fine-mapping of the HNF 1 B multicancer locus identi fi es candidate variants thatmediate endometrial cancer risk

  2015cites this paper
• A review on hepatocyte nuclear factor-1beta and tumor

  2015influential citation
• Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk

  2014cites this paper
• Expression of Bile Duct Transcription Factor HNF1β Predicts Early Tumor Recurrence and Is a Stage-Independent Prognostic Factor in Hepatocellular Carcinoma

  2014cites this paper
• Caractérisation de l’effet de mutations MODY sur la fonction de bookmarking de HNF1beta

  2014cites this paper
• Significant variation of immunohistochemical marker expression in paired primary and metastatic clear cell renal cell carcinomas.

  2013cites this paper
• MicroRNAs as Predictive and Prognostic Biomarkers inHuman Neoplasia: With Specific Focus on Colorectal Cancer, Giant Cell Tumor of Bone, and Leukemias

  2013cites this paper
• MicroRNA profiling differentiates colorectal cancer according to KRAS status

  2012cites this paper
• Decreased expression of dual-specificity phosphatase 9 is associated with poor prognosis in clear cell renal cell carcinoma

  2011cites this paper
• Large-scale fine mapping of the HNF1B locus and prostate cancer risk.

  2011cites this paper